Identifying disease modifying genes in multiple sclerosis

被引:100
|
作者
Kantarci, OH
de Andrade, M
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
multiple sclerosis; genetics; prognosis; severity; course; outcome;
D O I
10.1016/S0165-5728(01)00481-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes, The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the cur-rent state of knowledge in this area. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:144 / 159
页数:16
相关论文
共 50 条
  • [1] Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis
    S. V. Ramagopalan
    G. C. DeLuca
    K. M. Morrison
    B. M. Herrera
    D. A. Dyment
    M. R. Lincoln
    S.-M. Orton
    M. J. Chao
    A. Degenhardt
    M. Pugliatti
    A. D. Sadovnick
    S. Sotgiu
    G. C. Ebers
    Journal of Neurology, 2008, 255
  • [2] Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis
    Ramagopalan, Sreeram V.
    DeLuca, Gabriele C.
    Morrison, Katie M.
    Herrera, Blanca M.
    Dyment, David A.
    Lincoln, Matthew R.
    Orton, Sarah-Michelle
    Chao, Michael J.
    Degenhardt, Alexandra
    Pugliatti, Maura
    Sadovnick, A. Dessa
    Sotgiu, Stefano
    Ebers, George C.
    JOURNAL OF NEUROLOGY, 2008, 255 (08) : 1215 - 1219
  • [3] "Disease modifying nutricals" for multiple sclerosis
    Schmitz, Katja
    Barthelmes, Julia
    Stolz, Leonie
    Beyer, Susanne
    Diehl, Olaf
    Tegeder, Irmgard
    PHARMACOLOGY & THERAPEUTICS, 2015, 148 : 85 - 113
  • [4] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [5] Disease modifying treatment in multiple sclerosis
    Fuller, GN
    Bone, I
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 : II20 - II21
  • [6] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [7] Disease modifying therapies in multiple sclerosis - Reply
    Goodin, DS
    NEUROLOGY, 2002, 59 (03) : 472 - 473
  • [8] Disease-modifying therapy for multiple sclerosis
    Holmoy, Trygve
    Myhr, Kjell-Morten
    Bo, Lars
    Nygaard, Gro Owren
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (08) : 723 - 726
  • [9] Disease modifying therapies for relapsing multiple sclerosis
    Wingerchuk, Dean M.
    Weinshenker, Brian G.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [10] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26